| All PCs (n = 311, 143 BCR) | ||||||||
---|---|---|---|---|---|---|---|---|---|
 | Univariate | Multivariatea | Multivariateb | ||||||
Variable | HR (95Â % CI) | p value | C-index | HR (95Â % CI) | p value | HR (95Â % CI) | p value | C-indexc | C-indexd |
5hmC score (cont.) | 1.53 (1.09–2.15) | 0.013 | 0.57 | 1.58 (1.12–2.23) | 0.009 | 1.62 (1.15–2.28) | 0.006 | 0.75 |  |
Pre-op. PSA (≤10 vs. >10 ng/ml) | 2.93 (2.00–4.29) | <0.001 | 0.63 | 2.17 (1.46–3.24) | <0.001 | 2.17 (1.46–3.24) | <0.001 |  | 0.75 |
Surgical margin (neg. vs. pos.) | 2.86 (2.04–4.00) | <0.001 | 0.63 | 1.99 (1.38–2.86) | <0.001 | 1.99 (1.38–2.86) | <0.001 |  |  |
Tumor stage (pT2 vs. pT3-4) | 2.96 (2.13–4.13) | <0.001 | 0.64 | 1.91 (1.32–2.76) | 0.001 | 1.90 (1.32–2.75) | 0.001 |  |  |
Gleason score (≤6 vs. >6) | 2.67 (1.70–4.17) | <0.001 | 0.58 | 2.08 (1.30–3.34) | <0.002 | 2.02 (1.26–3.23) | 0.003 |  |  |
ERG status (neg. vs. pos.) | 1.06 (0.76–1.48) | 0.732 | 0.51 | 1.19 (0.85–1.68) | 0.314 | – | – |  |  |